| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| zp2929 | glucagon | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Complications of Diabetes Mellitus[MeSHID:D048909] Diabetes Mellitus Insulin-Dependent[MeSHID:D003922] Obesity[MeSHID:D009765] |
NA | phase 1 | unknown |
| zp2929 | glucagon receptor | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Complications of Diabetes Mellitus[MeSHID:D048909] Diabetes Mellitus Insulin-Dependent[MeSHID:D003922] Obesity[MeSHID:D009765] |
NA | phase 1 | unknown |
| zp2929 | glucagon-like peptide 1 receptor | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Complications of Diabetes Mellitus[MeSHID:D048909] Diabetes Mellitus Insulin-Dependent[MeSHID:D003922] Obesity[MeSHID:D009765] |
NA | phase 1 | unknown |
| click here to return to the previous page | ||||||||